MABp1 to improve clinical outcomes of patients with symptomatic refractory metastatic colorectal cancer patients: Per-protocol population analysis of phase III study (P1026).
Authors: Wyrwicz, L., Saunders, M.P., Andre, T., Sarosiek, T., Nemecek, R., Rogowski, W., Leniewski-Kmak, K., Fisher, G.A., Stecher, M., Mohanty, P., Simard, J., Hickish, T.
Journal: JOURNAL OF CLINICAL ONCOLOGY
Publication Date: 20/05/2017
Volume: 35
eISSN: 1527-7755
ISSN: 0732-183X
DOI: 10.1200/JCO.2017.35.15_suppl.3530
Source: Web of Science